WHAT
MAKES US
UNIQUE

Aaron Ciechanover, MD, DSc

“T3 with its team of experts, has accompanied us in our efforts to commercialize our ubiquitin system-related discoveries. From connecting us to the best patent attorneys, all the way to negotiating multi-partner contracts, and now helping us in preparing for Phase 1 clinical trials. All along we’ve felt we are in the best hands possible.”

Aaron Ciechanover, MD, DSc

Laureate, the 2004 Nobel Prize in Chemistry
Distinguished University Professor
Faculty of Medicine, Technion-Israel Institute of Technology
Founder, TRIPOD Therapeutics Ltd.

Prof. Timor Baasov

“Without the T3’s continues professional guidance at , I would have never thought of commercializing my research, which is currently in Phase-II clinical trials.”

Prof. Timor Baasov

Faculty of Chemistry, Technion-Israel Institute of Technology
Founder, Eloxx Pharmaceuticals Inc.

Prof. Eyal Gottlieb

“The team at T3 dealt with the transfer of knowhow to my spin-off company very professionally and effectively. They also enabled collaborations with the company over the years, thereby promoting the research at both my lab and the company.”

Prof. Eyal Gottlieb

Faculty of Medicine, Technion-Israel Institute of Technology
Director, the Rappaport Institute for Medical Research
Founder, MetaboMed Ltd.

Michal Amit PhD

“We have worked closely with the T3 team over the years and feel the great impact of its commitment to our success.”

Michal Amit PhD

CEO & CTO, ACCELLTA Ltd.

Tomer Fuchs

“The T3 team has made a huge difference throughout the company’s life from the inception of Sealantis – founded by Prof. Havazelet Binco-Peled, to its acquisition by AMS.”

Tomer Fuchs

Project Director
Advanced Medical Solutions Israel (Sealantis) Ltd.

Prof. Avi Schroeder

“T3’s professional team bridges the science and business needs in each project, constructing successful new companies and long-lasting industrial collaborations.”

Prof. Avi Schroeder

Faculty of Chemical Engineering, Technion-Israel Institute of Technology
Founder, Barcode Diagnostics Ltd., ViAqua Therapeutics Ltd., Inplant Technologies Ltd., RNAWAY Ltd., Mana-BIO Ltd.

Doron D. Patt

“The T3 team provided invaluable access to the Technion’s faculty when scientific authority and guidance were needed for our R&D projects.”

Doron D. Patt

CEO & Co-Chairman, SLP Ltd.
Founded by Prof. Peretz Lavie

OUR
SUCCESS
STORIES

LATEST NEWS

What Do Espresso, Oil, and Microgels Have in Common?
New Study Could Lead to Gene Therapy for Cancer and Brain Diseases
Technion researchers have developed a new chemical process: triazenolysis
Who Moved My Atom?
Multipurpose Memory
Innovative Technology Expected to Significantly Improve the Use of MRI Scans.
Research at the Technion’s Faculty of Biology Paves the Way for Innovative Lung Cancer Treatment
Water From the Air
Processed Food – Nothing to Panic About
Breakthrough in Mechanobiology – Precise Measurement of Forces in Biological Processes
Technion Industrial Design Graduate Wins Prestigious Design Award for Designing a Post-Mastectomy 3D-Printed Bra
Ultrasound for Drug Delivery
The Technion: First Place in Israeli Academia According to Globes Brand Index
When the Brain Speaks, the Heart Feels It
Gut Bacteria and the Immune System
Cancer Patient Response to Immunotherapy
A Leap Towards Male Infertility Diagnostics
At the Forefront of Regenerative Therapies for Spinal Cord Injuries
Technion’s next step towards green hydrogen fuel cells production.
A New Era of Clean Energy
A New Breakthrough in AI Software
Technion Patents in the Top 100 Worldwide!
Atomic-scale spin-optical laser: new horizon for optoelectronics
A Key Step Towards the Efficient Production of Computer Chips
Waves of Migration?